The Journal of Urology
Volume 174, Issue 2 , Pages 590-594, August 2005

EFFECT OF CRANBERRY JUICE CONSUMPTION ON URINARY STONE RISK FACTORS

  • MATTHEW T. GETTMAN

      Affiliations

    • Corresponding Author InformationNothing to disclose.
  • ,
  • KENNETH OGAN

      Affiliations

    • Corresponding Author InformationNothing to disclose.
  • ,
  • LINDA J. BRINKLEY

      Affiliations

    • Corresponding Author InformationNothing to disclose.
  • ,
  • BEVERLEY ADAMS-HUET

      Affiliations

    • Corresponding Author InformationNothing to disclose.
  • ,
  • CHARLES Y.C. PAK

      Affiliations

    • Corresponding Author InformationNothing to disclose.
  • ,
  • MARGARET S. PEARLE

      Affiliations

    • Corresponding Author InformationCorrespondence: Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9110 (telephone: 214-648-6853; FAX: 214-648-8786).
    • Corresponding Author InformationFinancial interest and/or other relationship with Cook Urological, Inc., Applied Medical, Boston Scientific and Percutaneous Systems, Inc.

Department of Urology, Mayo Clinic, Rochester, Minnesota (MTG), and the Department of Urology (KO, MSP), Jane and Charles Pak Center for Mineral Metabolism and Clinical Research (LJB, BAH, CYCP, MSP), University of Texas Southwestern Medical Center, Dallas, Texas

Accepted 26 October 2004.

ABSTRACT 

Purpose

We evaluated the effect of cranberry juice on urinary stone risk factors.

Materials and Methods

A total of 12 normal subjects and 12 calcium oxalate stone formers underwent 2, 7-day phases of study in random order while on a controlled metabolic diet. Subjects ingested 1 l of cranberry juice (CBJ) daily in 1 phase and 1 l of deionized water in the other phase. On the last 2 days of each phase 2, 24-hour urine collections and blood samples were obtained for stone risk factors and serum chemistries.

Results

No significant differences were found between normal subjects and stone formers in response to CBJ and, therefore, the groups were combined. CBJ significantly increased urinary calcium (from 154 to 177 mg per day, p =0.0008) and urinary oxalate (from 26.4 to 29.2 mg per day, p =0.04), thereby increasing urinary saturation of calcium oxalate by 18%. Urinary citrate was unchanged and urinary magnesium increased slightly. Urinary pH decreased (from 5.97 to 5.67, p =0.0005), and urinary ammonium, titratable acidity and net acid excretion increased during CBJ ingestion. Urinary uric acid decreased (from 544 to 442 mg per day, p <0.0001) as did serum uric acid. Thus, the urinary saturation of brushite and monosodium urate was reduced by CBJ but the amount of undissociated uric acid increased.

Conclusions

CBJ exerts a mixed effect on urinary stone forming propensity. It reduces urinary pH likely by providing an acid load and decreases urinary uric acid perhaps by retarding urate synthesis. Overall CBJ increases the risk of calcium oxalate and uric acid stone formation but decreases the risk of brushite stones.

Key Words:  kidney calculi , oxalates , vaccinium macrocarpon

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by United States Public Health Service Grants M01-RR00633 and P01-DK20543 from the National Institutes of Health.Study received Institutional Review Board approval.Editor’s Note: This article is the third of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 800 and 801.

PII: S0022-5347(01)68322-8

doi:10.1097/01.ju.0000165168.68054.f8

The Journal of Urology
Volume 174, Issue 2 , Pages 590-594, August 2005